Literature DB >> 18048769

Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia.

Thao P Nguyen1, Dao W Wang, Thomas H Rhodes, Alfred L George.   

Abstract

Mutations in SCN5A encoding the principal Na+ channel alpha-subunit expressed in human heart (Na(V)1.5) have recently been linked to an inherited form of dilated cardiomyopathy with atrial and ventricular arrhythmia. We compared the biophysical properties of 2 novel Na(V)1.5 mutations associated with this syndrome (D2/S4--R814W; D4/S3--D1595H) with the wild-type (WT) channel using heterologous expression in cultured tsA201 cells and whole-cell patch-clamp recording. Expression levels were similar among WT and mutant channels, and neither mutation affected persistent sodium current. R814W channels exhibited prominent and novel defects in the kinetics and voltage dependence of activation characterized by slower rise times and a hyperpolarized conductance-voltage relationship resulting in an increased "window current." This mutant also displayed enhanced slow inactivation and greater use-dependent reduction in peak current at fast pulsing frequencies. By contrast, D1595H channels exhibited impaired fast inactivation characterized by slower entry into the inactivated state and a hyperpolarized steady-state inactivation curve. Our findings illustrate the divergent biophysical defects caused by 2 different SCN5A mutations associated with familial dilated cardiomyopathy. Retrospective review of the published clinical data suggested that cardiomyopathy was not common in the family with D1595H, but rather sinus bradycardia was the predominant clinical finding. However, for R814W, we speculate that an increased window current coupled with enhanced slow inactivation and rate-dependent loss of channel availability provided a unique substrate predisposing myocytes to disordered Na+ and Ca2+ homeostasis leading to myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048769     DOI: 10.1161/CIRCRESAHA.107.164673

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts.

Authors:  Chuan Wang; Jessica A Hennessey; Robert D Kirkton; Chaojian Wang; Victoria Graham; Ram S Puranam; Paul B Rosenberg; Nenad Bursac; Geoffrey S Pitt
Journal:  Circ Res       Date:  2011-08-04       Impact factor: 17.367

2.  Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.

Authors:  Hiroshi Watanabe; Tao Yang; Dina Myers Stroud; John S Lowe; Louise Harris; Thomas C Atack; Dao W Wang; Susan B Hipkens; Brenda Leake; Lynn Hall; Sabina Kupershmidt; Nagesh Chopra; Mark A Magnuson; Naohito Tanabe; Björn C Knollmann; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

3.  SCN5A variant R222Q generated abnormal changes in cardiac sodium current and action potentials in murine myocytes and Purkinje cells.

Authors:  Laura L Daniel; Tao Yang; Brett Kroncke; Lynn Hall; Dina Stroud; Dan M Roden
Journal:  Heart Rhythm       Date:  2019-05-21       Impact factor: 6.343

4.  Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia.

Authors:  Lisa L Murphy; Anita J Moon-Grady; Bettina F Cuneo; Ronald T Wakai; Suhong Yu; Jennifer D Kunic; D Woodrow Benson; Alfred L George
Journal:  Heart Rhythm       Date:  2011-11-07       Impact factor: 6.343

5.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

6.  Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.

Authors:  Thomas M Beckermann; Karen McLeod; Victoria Murday; Franck Potet; Alfred L George
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

7.  LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.

Authors:  Teng Zhang; Sandro L Yong; Jeanne K Drinko; Zoran B Popović; John C Shryock; Luiz Belardinelli; Qing Kenneth Wang
Journal:  Int J Cardiol       Date:  2009-09-17       Impact factor: 4.164

8.  Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice.

Authors:  Elaine Wan; Jeffrey Abrams; Richard L Weinberg; Alexander N Katchman; Joseph Bayne; Sergey I Zakharov; Lin Yang; John P Morrow; Hasan Garan; Steven O Marx
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

9.  Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy.

Authors:  Jessica R Golbus; Megan J Puckelwartz; Lisa Dellefave-Castillo; John P Fahrenbach; Viswateja Nelakuditi; Lorenzo L Pesce; Peter Pytel; Elizabeth M McNally
Journal:  Circ Cardiovasc Genet       Date:  2014-09-01

Review 10.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.